Pharmaceutical CDMO Services Market Insights, Global Outlook and Forecast 2022-2028
Pharmaceutical CDMO Services Market Insights, Global Outlook and Forecast 2022-2028
The Pharmaceutical CDMO Services Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
The latest research study released by Market IntelliX evaluates market size and forecasts of Pharmaceutical CDMO Services in Global, including the following market information:
Global Pharmaceutical CDMO Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical CDMO Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Substance Development and Manufacturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited and Piramal Pharma Solutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Pharmaceutical CDMO Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Pharmaceutical CDMO Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Type, 2021 (%)
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Global Pharmaceutical CDMO Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Application, 2021 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Global Pharmaceutical CDMO Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Services revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Services Overall Market Size
2.1 Global Pharmaceutical CDMO Services Market Size: 2021 VS 2028
2.2 Global Pharmaceutical CDMO Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical CDMO Services Players in Global Market
3.2 Top Global Pharmaceutical CDMO Services Companies Ranked by Revenue
3.3 Global Pharmaceutical CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical CDMO Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutical CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pharmaceutical CDMO Services Market Size Markets, 2021 & 2028
4.1.2 Drug Substance Development and Manufacturing
4.1.3 Specialized Services
4.1.4 Lab-based Services
4.2 By Type - Global Pharmaceutical CDMO Services Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical CDMO Services Revenue, 2017-2022
4.2.2 By Type - Global Pharmaceutical CDMO Services Revenue, 2023-2028
4.2.3 By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical CDMO Services Market Size, 2021 & 2028
5.1.2 Innovative Medicine
5.1.3 Patented Drug
5.1.4 Patent Expired Drug
5.2 By Application - Global Pharmaceutical CDMO Services Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical CDMO Services Revenue, 2017-2022
5.2.2 By Application - Global Pharmaceutical CDMO Services Revenue, 2023-2028
5.2.3 By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pharmaceutical CDMO Services Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutical CDMO Services Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical CDMO Services Revenue, 2017-2022
6.2.2 By Region - Global Pharmaceutical CDMO Services Revenue, 2023-2028
6.2.3 By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmaceutical CDMO Services Revenue, 2017-2028
6.3.2 US Pharmaceutical CDMO Services Market Size, 2017-2028
6.3.3 Canada Pharmaceutical CDMO Services Market Size, 2017-2028
6.3.4 Mexico Pharmaceutical CDMO Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical CDMO Services Revenue, 2017-2028
6.4.2 Germany Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.3 France Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.4 U.K. Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.5 Italy Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.6 Russia Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.8 Benelux Pharmaceutical CDMO Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical CDMO Services Revenue, 2017-2028
6.5.2 China Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.3 Japan Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.4 South Korea Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.6 India Pharmaceutical CDMO Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmaceutical CDMO Services Revenue, 2017-2028
6.6.2 Brazil Pharmaceutical CDMO Services Market Size, 2017-2028
6.6.3 Argentina Pharmaceutical CDMO Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, 2017-2028
6.7.2 Turkey Pharmaceutical CDMO Services Market Size, 2017-2028
6.7.3 Israel Pharmaceutical CDMO Services Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutical CDMO Services Market Size, 2017-2028
6.7.5 UAE Pharmaceutical CDMO Services Market Size, 2017-2028
7 Players Profiles
7.1 Recipharm AB
7.1.1 Recipharm AB Corporate Summary
7.1.2 Recipharm AB Business Overview
7.1.3 Recipharm AB Pharmaceutical CDMO Services Major Product Offerings
7.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.1.5 Recipharm AB Key News
7.2 AMRI Global
7.2.1 AMRI Global Corporate Summary
7.2.2 AMRI Global Business Overview
7.2.3 AMRI Global Pharmaceutical CDMO Services Major Product Offerings
7.2.4 AMRI Global Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.2.5 AMRI Global Key News
7.3 Patheon N.V.
7.3.1 Patheon N.V. Corporate Summary
7.3.2 Patheon N.V. Business Overview
7.3.3 Patheon N.V. Pharmaceutical CDMO Services Major Product Offerings
7.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.3.5 Patheon N.V. Key News
7.4 Aenova Group
7.4.1 Aenova Group Corporate Summary
7.4.2 Aenova Group Business Overview
7.4.3 Aenova Group Pharmaceutical CDMO Services Major Product Offerings
7.4.4 Aenova Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.4.5 Aenova Group Key News
7.5 Catalent, Inc.
7.5.1 Catalent, Inc. Corporate Summary
7.5.2 Catalent, Inc. Business Overview
7.5.3 Catalent, Inc. Pharmaceutical CDMO Services Major Product Offerings
7.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.5.5 Catalent, Inc. Key News
7.6 Amatsigroup
7.6.1 Amatsigroup Corporate Summary
7.6.2 Amatsigroup Business Overview
7.6.3 Amatsigroup Pharmaceutical CDMO Services Major Product Offerings
7.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.6.5 Amatsigroup Key News
7.7 WuXi AppTec Group
7.7.1 WuXi AppTec Group Corporate Summary
7.7.2 WuXi AppTec Group Business Overview
7.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Major Product Offerings
7.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.7.5 WuXi AppTec Group Key News
7.8 Strides Pharma Science Limited
7.8.1 Strides Pharma Science Limited Corporate Summary
7.8.2 Strides Pharma Science Limited Business Overview
7.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Major Product Offerings
7.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.8.5 Strides Pharma Science Limited Key News
7.9 Piramal Pharma Solutions
7.9.1 Piramal Pharma Solutions Corporate Summary
7.9.2 Piramal Pharma Solutions Business Overview
7.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Major Product Offerings
7.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.9.5 Piramal Pharma Solutions Key News
7.10 Siegfried Ltd
7.10.1 Siegfried Ltd Corporate Summary
7.10.2 Siegfried Ltd Business Overview
7.10.3 Siegfried Ltd Pharmaceutical CDMO Services Major Product Offerings
7.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.10.5 Siegfried Ltd Key News
7.11 Fareva Group
7.11.1 Fareva Group Corporate Summary
7.11.2 Fareva Group Business Overview
7.11.3 Fareva Group Pharmaceutical CDMO Services Major Product Offerings
7.11.4 Fareva Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.11.5 Fareva Group Key News
7.12 FAMAR Health Care Services
7.12.1 FAMAR Health Care Services Corporate Summary
7.12.2 FAMAR Health Care Services Business Overview
7.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Major Product Offerings
7.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.12.5 FAMAR Health Care Services Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Pharmaceutical CDMO Services Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|